The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.
Lumen Biosciences Brian Finrow breaks down Chinas biotech playbook and explores ways the U.S. can adapt it for its own continued success.
The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...
The upcoming EU Biotech Act may be more prominently focused on health. But it will also significantly impact food and food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback